HSCS: HeartSciences Projected Price to Earnings

Heart Test Laboratories (HSCS) is recruiting leading data scientists to process cardiac data. The issuer's forward P/E, as shown on this GURU.Markets chart, currently holds around 0.00, reflecting the market valuation dynamics relative to earnings. Management aims to commercialize the MyoVista system through insurance reimbursements, while business success relies on the accuracy of AI algorithms and regulatory approval in primary care.

Market Cap to Projected Earnings: heartsciences.com (HSCS) for 04/28/2023 - 11/10/2026

Analytical breakdowns and data insights for company Heart Test Labs (HSCS)

- stock value and consensus price forecast:

Price Chart HeartSciences|HSCS - Price Target Chart

- market capitalization information:

Market Valuation Heart Test Laboratories, Inc.|HSCS - Total Enterprise Value

- issuer book value statistics:

Net Assets per Single Share HeartSciences|HSCS - Book Valuation of Business|Market Capitalization to Book Value Ratio heartsciences.com|HSCS - Company Total Asset Base

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

HSCS - Final Profit|Future Profit Heart Test Laboratories|HSCS - Market Price to Net Income Ratio|Projected Price to Earnings Heart Test Laboratories Inc.|HSCS - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Heart Test Laboratories, Inc.|HSCS - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) HeartSciences|HSCS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months heartsciences.com|HSCS - Expected net earnings per share growth this year|Expected earnings per share growth for next year Heart Test Laboratories

Fundamental valuation:HeartSciences

Heart Test Laboratories specializes in providing high-cost, secure transportation of high-precision cardiology systems to clinics. By analyzing the company's forward P/E NTM, an investor assesses the current share price relative to expected earnings, which helps determine whether the business is overvalued or if the asset is undervalued, accounting for inflationary risks and the cost of capital.

Competitors of Heart Test Laboratories (HSCS)